dalteparin has been researched along with Nephrotic Syndrome in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Low-molecular-weight heparin (LMWH) has a longer plasma half-life and better bioavailability than standard heparin and can thus be administered as a single daily injection." | 3.78 | Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin. ( Ben Maadi, A; Durand-Zaleski, I; Jazaerli, N; Mathieu, D; Petit-Phar, M; Radier, C; Rahmouni, A; Rosso, J; Rostoker, G; Vasile, N, 1995) |
| "The management of a patient with venous thrombosis with perinephric hematoma post renal biopsy can be difficult if occurred." | 1.72 | Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. ( Daud, MAM; Kamarudin, MI; Nadarajan, C, 2022) |
| " Enoxaparin dosing was nearly double the recommended starting doses for secondary thromboprophylaxis." | 1.62 | Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort. ( Dobbie, LJ; Eskell, L; Lamb, A; Ramage, IJ; Reynolds, BC, 2021) |
| " In hemodialysis patients, enoxaparin at once daily reduced dosing should be considered with trough and peak anti-Xa levels monitoring." | 1.62 | Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction: Challenging Cases and Practical Algorithms. ( Bahabri, A; Belostosky, V; Bhatt, MD; Chan, AKC, 2021) |
| "Presumptive diagnosis of pulmonary embolism was made and the patient was given 1000IU of antithrombin III and nadroparine (2x90IU/kg/24h s." | 1.48 | [Pulmonary embolism in a girl with nephrotic syndrome and factor V Leiden - case report]. ( Biejat, A; Brzewski, M; Kucińska, B; Kułagowska, J; Mizerska-Wasiak, M; Ofiara, A; Pańczyk-Tomaszewska, M; Skrzypczyk, P; Szyszka, M; Werner, B, 2018) |
| "Membranous nephropathy is uncommon in Chinese children and could be a possible early presentation of SLE." | 1.36 | An unusual case of loin pain and nephritis. ( Chiu, MC; Lai, WM; Ma, AL, 2010) |
| "Nephrotic syndrome is known to be associated with thrombosis but rarely of cerebral vessels." | 1.30 | [Superior sagittal sinus thrombosis and nephrotic syndrome: favorable outcome with low molecular weight heparin]. ( Christmann, D; de Saint-Martin, A; Fischbach, M; Knab, MC; Peter, MO; Terzic, J, 1997) |
| " These results are similar to those obtained with the same dosage in other clinical settings." | 1.29 | Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome. ( Aiach, M; Alhenc-Gelas, M; Jacquot, C; Rossert, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Skrzypczyk, P | 1 |
| Mizerska-Wasiak, M | 1 |
| Ofiara, A | 1 |
| Szyszka, M | 1 |
| Kułagowska, J | 1 |
| Biejat, A | 1 |
| Brzewski, M | 1 |
| Kucińska, B | 1 |
| Werner, B | 1 |
| Pańczyk-Tomaszewska, M | 1 |
| Artoni, A | 1 |
| Passamonti, SM | 1 |
| Edefonti, A | 1 |
| Gianniello, F | 1 |
| Civelli, V | 1 |
| Martinelli, I | 1 |
| Alhenc-Gelas, M | 1 |
| Rossert, J | 1 |
| Jacquot, C | 1 |
| Aiach, M | 1 |
| Kamarudin, MI | 1 |
| Nadarajan, C | 1 |
| Daud, MAM | 1 |
| Dobbie, LJ | 1 |
| Lamb, A | 1 |
| Eskell, L | 1 |
| Ramage, IJ | 1 |
| Reynolds, BC | 1 |
| Bahabri, A | 1 |
| Chan, AKC | 1 |
| Belostosky, V | 1 |
| Bhatt, MD | 1 |
| Ma, AL | 1 |
| Lai, WM | 1 |
| Chiu, MC | 1 |
| Rostoker, G | 1 |
| Durand-Zaleski, I | 1 |
| Petit-Phar, M | 1 |
| Ben Maadi, A | 1 |
| Jazaerli, N | 1 |
| Radier, C | 1 |
| Rahmouni, A | 1 |
| Mathieu, D | 1 |
| Vasile, N | 1 |
| Rosso, J | 1 |
| de Saint-Martin, A | 1 |
| Terzic, J | 1 |
| Christmann, D | 1 |
| Knab, MC | 1 |
| Peter, MO | 1 |
| Fischbach, M | 1 |
1 review available for dalteparin and Nephrotic Syndrome
| Article | Year |
|---|---|
Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin.
Topics: Adult; Biopsy; Cohort Studies; Enoxaparin; Female; Humans; Incidence; Kidney; Male; Middle Aged; Nep | 1995 |
1 trial available for dalteparin and Nephrotic Syndrome
| Article | Year |
|---|---|
Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin.
Topics: Adult; Biopsy; Cohort Studies; Enoxaparin; Female; Humans; Incidence; Kidney; Male; Middle Aged; Nep | 1995 |
8 other studies available for dalteparin and Nephrotic Syndrome
| Article | Year |
|---|---|
[Pulmonary embolism in a girl with nephrotic syndrome and factor V Leiden - case report].
Topics: Adolescent; Anticoagulants; Antithrombin III; Factor V; Female; Humans; Mycophenolic Acid; Nadropari | 2018 |
Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency.
Topics: Adolescent; Anticoagulants; Biopsy; Heparin; Humans; International Normalized Ratio; Intracranial Th | 2016 |
Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome.
Topics: Adult; Aged; Anticoagulants; Female; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Male; Middle | 1995 |
Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy.
Topics: Adult; Biopsy; Enoxaparin; Gastrointestinal Hemorrhage; Hematoma; Hematuria; Humans; Kidney Diseases | 2022 |
Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort.
Topics: Anticoagulants; Child; Enoxaparin; Hemorrhage; Humans; Nephrotic Syndrome; Thrombosis; Venous Thromb | 2021 |
Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction: Challenging Cases and Practical Algorithms.
Topics: Acute Kidney Injury; Algorithms; Anticoagulants; Child; Child, Preschool; Drug Monitoring; Enoxapari | 2021 |
An unusual case of loin pain and nephritis.
Topics: Adolescent; Cyclosporine; DNA; Enoxaparin; Female; Glomerulonephritis, Membranous; Humans; Immunosup | 2010 |
[Superior sagittal sinus thrombosis and nephrotic syndrome: favorable outcome with low molecular weight heparin].
Topics: Anticoagulants; Brain; Child, Preschool; Enoxaparin; Female; Humans; Nephrotic Syndrome; Sinus Throm | 1997 |